Microsoft and Qualcomm have made important improvements to compatibility and performance for games on Snapdragon CPUs. Microsoft and Qualcomm have made important improvements to compatibility and ...

What Is Uzedy, and Why Does It Matter? Uzedy is a long-acting injectable form of risperidone, a medicine used to treat serious mental health conditions like schizophrenia and bipolar I disorder (BD-I) ...

Ever wonder where your income puts you compared to the rest of the country? I do. Not in a comparison-obsessed way, but more like a quick "Am I doing OK?" check-in kind of thing. The U.S. Census ...

SAN FRANCISCO, Oct 1 (Reuters) - Qualcomm has shifted its flagship chips to the latest generation of Arm Holdings' computing architecture with new features aimed at better AI performance, sources ...

The FDA approved a subcutaneous formulation of the blockbuster cancer drug pembrolizumab (Keytruda Qlex) for use across the drug's numerous solid tumors indications. The new formulation combines ...

Compared with placebo, significantly greater proportions of patients treated with Tremfya achieved clinical remission and endoscopic improvement. HealthDay News — The US Food and Drug Administration ...

Merck (NYSE:MRK) said that the FDA has cleared Keytruda Qlex, a new subcutaneous version of its blockbuster cancer drug, offering a faster alternative to IV infusion, a company spokesperson confirmed ...

The FDA has approved Merck & Co.’s under-the-skin version of Keytruda, reducing treatment time burden for patients while granting the world’s bestselling drug potential blockbuster revenue protection.

Subcutaneous pembrolizumab with berahyaluronidase alfa is FDA-approved for all solid tumor indications, including metastatic nonsquamous NSCLC. The phase 3 3475A-D77 trial confirmed noninferior ...

Ozempic (semaglutide) is injected once weekly under the skin of your abdomen, upper arm, or thigh. Your doctor will show you how to do this before your first dose. To prevent skin issues, rotate your ...

Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence. Ascletis Pharma, Inc. ( (HK:1672)) has ...